City of Hope, TGen looking to create personalized roadmaps for treatment of kidney cancer

Experts at City of Hope and the Translational Genomics Research Institute (TGen) are using one of the world’s most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients. ”The hope is to one day identify patients who will benefit from immunotherapy and those who will not. Eventually we may be able to distinguish which patient is better…